4.7 Article

Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients

Related references

Note: Only part of the references are listed.
Article Cell Biology

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β

Alessandra Metelli et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Medicine, General & Internal

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Hematology

Bleeding incidence and risk factors among cancer patients treated with anticoagulation

Dana E. Angelini et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Article Immunology

Myeloid cell-synthesized coagulation factor X dampens antitumor immunity

Claudine Graf et al.

SCIENCE IMMUNOLOGY (2019)

Article Medicine, General & Internal

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

R. J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Health Care Sciences & Services

Bleeding in cancer patients and its treatment: a review

Candice Johnstone et al.

ANNALS OF PALLIATIVE MEDICINE (2018)

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

Article Medicine, General & Internal

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Martin Reck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)